Market Size of Ureteroscopes Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Ureteroscopes Market Analysis
The ureteroscopes market is expected to register a CAGR of nearly 5.6% during the forecast period.
The spread of COVID19 across the world affected the delivery of healthcare services. Ureteroscopes had probably been the hardest hit subspecialty in urology with a massive cut down in outpatient urological investigations and procedures and urological operations. As per the August 2021 published study in PubMed, during the pandemic, patients with symptomatic kidney stones expressed anxiety regarding outpatient encounters and reluctance toward procedural intervention. Also, as per the November 202 published study in Elsevier, there has been a significant reduction in emergency admissions for urolithiasis, during the COVID-19 pandemic in Rome.
Furthermore, in another study published in September 2021, a considerable reduction was seen in overall admissions for the treatment of urolithiasis in the Brazilian public healthcare system during the first year of the COVID-19 pandemic. Women and individuals older than 60 years were especially affected. It was also stated that October 2020 and November 2020 were the least affected, probably due to the decline in the pandemic burden. On the other hand, urgent procedures significantly increased during 2020, when compared to 2017-2020. Thus, COVID-19 had a significant impact on the market.
The ureteroscopes market is expected to increase due to certain factors such as rising kidney and urinary disorders along with the rising geriatric population. For instance, as per the March 2022 published article by NIH, chronic kidney disease is a progressive condition that affects ~10% of the general population worldwide, amounting to more than 800 million individuals. Chronic kidney disease has emerged as one of the leading causes of mortality worldwide, and it is one of a small number of non-communicable diseases that have shown an increase in associated deaths over the past few decades.
Also, as per the CDC's 2021 data, chronic kidney disease affects more than one in seven US adults, an estimated 37 million Americans. It also stated that one in three adults in the United States (approximately 80 million) is at risk of kidney disease. The same source stated that while Americans with diabetes or high blood pressure are most prone to kidney disease, nearly one in three people with diabetes and one in five people with high blood pressure have kidney disease. As a result, the increasing prevalence of kidney disease is likely to support market growth.
However, the high cost of ureteroscopes is likely to hamper the growth of the market.
